• xxx


Professor Fiona Thistlethwaite is a Medical Oncology Consultant within the ECMT (Experimental Cancer Medicine Team) at The Christie NHS Foundation Trust and Honorary Professor of Experimental Immunotherapy at The University of Manchester.

Fiona has been actively involved in clinical trial development for many years with a research focus on early phase clinical trials in immune-oncology, particularly adoptive cell therapies, combination immunotherapies and immune biomarkers. She is the clinical lead for the Advanced Immune and Cell Therapy Team at The Christie and Medical Director of the NIHR Christie Clinical Research which is delivering over 400 oncology trials to patients each year. Fiona is also the Director of iMATCH (Innovate Manchester Advanced Therapy Centre Hub) which is a lead-centre within the UK-wide ATTC (Advanced Therapy Treatment Centre) network aiming to scale-up activity in the field of cell and gene therapy. In addition, Fiona is an active member of ESMO (European Society of Medical Oncology) acting as 2024 Congress Immunotherapy track chair.

UK Oncology Forum 2024

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.